Lala, Ceklic; Framme, Carsten; Wolf-Schnurrbusch, Ute E. K.; Wolf, Sebastian (2012). Three-year results of visual outcome with disease activity-guided ranibizumab algorithm for the treatment of exudative age-related macular degeneration. Acta ophthalmologica, 91(6), pp. 526-530. Oxford: Blackwell Munksgaard 10.1111/j.1755-3768.2012.02457.x
Full text not available from this repository.PURPOSE
To evaluate 3-year follow-up treatment outcomes with ranibizumab (Lucentis(®)) 0.5 mg administered either monthly or quarterly on a pro re nata (PRN) basis according to a disease activity-guided monitoring and treatment algorithm.
METHODS
A total of 316 treatment-naive eyes of 316 patients with exudative age-related macular degeneration met the criteria for inclusion in this retrospective, interventional case series. Patients were treated with ranibizumab 0.5 mg according to a disease activity-guided algorithm with monthly monitoring. Optical coherence tomography and fluorescein angiography were routinely used to assess disease activity: active lesions were treated with a series of three monthly injections, whereas inactive lesions were treated with quarterly injections.
RESULTS
Mean Early Treatment Diabetic Retinopathy Study best-corrected visual acuity improved from 52 letters at baseline to 59 letters at 12 months, achieved with a mean of 7.1 injections, 61 letters at 24 months with a mean of 5.0 injections administered in the second year and 60 letters at 36 months with a mean number of 5.2 injections.
CONCLUSIONS
Monthly visits and a morphology-driven PRN regimen with 3 injections in case of recurrence plus quarterly injections in case of inactive CNV resulted in an average VA gain of 7-9 letters that could be maintained over 3 years.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology |
UniBE Contributor: |
Framme, Carsten Karl Josef, Wolf-Schnurrbusch, Ute, Wolf, Sebastian (B) |
ISSN: |
1755-375X |
Publisher: |
Blackwell Munksgaard |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:23 |
Last Modified: |
05 Dec 2022 14:06 |
Publisher DOI: |
10.1111/j.1755-3768.2012.02457.x |
PubMed ID: |
22697404 |
Web of Science ID: |
000323201500025 |
Uncontrolled Keywords: |
antivascular endothelial growth factor, exudative age-related macular degeneration, optical coherence tomography, visual acuity |
URI: |
https://boris.unibe.ch/id/eprint/8108 (FactScience: 213590) |
Actions (login required)
 |
Edit item |